Colzyx
Lund
About Colzyx
Colzyx is based on ground breaking and innovative discoveries from the Medical Faculty at Lund University, Lund, Sweden. Their scientific work demonstrates that the alpha-3 chain from the human collagen VI molecule exhibits unprecedented wound healing and antimicrobial effects. These are used in Colzyx´ product development of novel and unique forms of advanced wound dressings for rapid wound healing. The products utilize naturally occurring, powerful biological regeneration mechanisms to accelerate the wound healing process and to protect the wound dressing against the whole spectrum of common and multidrug-resistant bacteria.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Last round: Grant (Oct 2019)
- Website: colzyx.com
- Phone: +46707686060
Industries & Categories
Biotechnology, Cosmetics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/colzyx-152284 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.